
-
Messi on target but Miami held by lowly Toronto
-
Inter's bold treble bid bumps up against past glory at Bayern Munich
-
Sagstrom digs deep to win LPGA Match Play
-
The music industry is battling AI -- with limited success
-
New app hopes to empower artists against AI
-
Haiti jazz festival is rare respite for violence-racked capital
-
Johnson satisfied after opening Grand Slam series event
-
China would have agreed TikTok deal if not for US tariffs: Trump
-
Harman keeps calm in the winds to clinch Texas Open
-
Doncic scores 30 as Lakers rout Thunder
-
Qualifier Brooksby stuns Tiafoe to win first ATP title
-
McLaughlin-Levrone seals Grand Slam jackpot with 400m victory
-
Juventus miss out on Serie A's top four with Roma draw
-
Marseille, Strasbourg win in Ligue 1 to close in on Champions League
-
Pegula wins WTA Charleston after Kenin collapse
-
Second US child dies of measles, almost 650 ill: officials
-
Thousands attend funeral of legendary Malian musician Amadou
-
Gaza rescuers say Israeli strikes kill 44
-
Alcaraz admits pressure to take Sinner's number one ranking 'killed' him
-
US storms, 'devastating' flooding death toll climbs to 17
-
Ovechkin achieves the 'impossible'
-
Ovechkin scores 895th goal to clinch all-time NHL record
-
Siraj's 4-17 helps Gujarat to hat-trick of IPL wins
-
Man City held by Man Utd in derby stalemate
-
'Minecraft Movie' strikes gold to dominate N.America box office
-
Strasbourg close in on Champions League with Ligue 1 win at Reims
-
Toulouse overpower Sale to reach rugby Champions Cup last eight
-
Slot shocked by sloppy Liverpool errors in Fulham defeat
-
Juric urges Southampton to learn from record-setting relegation
-
Italian director Moretti leaves hospital after heart attack
-
Chelsea's 'unfair' schedule to blame for Palmer axe: Maresca
-
Barrios grabs Atletico late Liga win at Sevilla
-
Le Pen slams 'witch hunt', vows not to give up at Paris rally
-
Liverpool's rare loss delays title march, Southampton relegated
-
World scrambles to temper Trump tariffs: White House
-
Southampton relegated from Premier League in record time
-
Fulham end Liverpool unbeaten league run to delay title party
-
Torrential rains kill dozens in DR Congo capital
-
Pogacar wins Van der Poel duel at cycling's Tour of Flanders
-
Djokovic plays down Monte Carlo hopes after eye infection
-
Israel targets Hezbollah in south Lebanon as US envoy visits
-
Bumrah 'available' for Mumbai's IPL clash with Bengaluru
-
Bordeaux book Champions Cup quarter-final with victory over Ulster
-
Israel's Netanyahu ends Hungary visit, heads to US
-
Fiji and New Zealand seal sevens wins in Singapore
-
Recovering Pope surprises crowd at Vatican square
-
UK readies to protect industry as US tariffs upend global order: Starmer
-
Tsunoda has 'mixed feelings' after 12th-place Red Bull debut
-
France's far-right, leftwingers rally supporters after Le Pen conviction
-
Hamilton says Ferrari still off the pace in Japan
GSK | -6.79% | 36.53 | $ | |
NGG | -5.25% | 65.93 | $ | |
RBGPF | 100% | 69.02 | $ | |
AZN | -7.98% | 68.46 | $ | |
BCC | 0.85% | 95.44 | $ | |
RYCEF | -18.79% | 8.25 | $ | |
SCS | -0.56% | 10.68 | $ | |
CMSD | 0.7% | 22.83 | $ | |
CMSC | 0.13% | 22.29 | $ | |
RIO | -6.88% | 54.67 | $ | |
JRI | -7.19% | 11.96 | $ | |
RELX | -6.81% | 48.16 | $ | |
VOD | -10.24% | 8.5 | $ | |
BTI | -5.17% | 39.86 | $ | |
BCE | 0.22% | 22.71 | $ | |
BP | -10.43% | 28.38 | $ |

DR Congo drug manufacturing plan sparks safety concerns
Sitting at his desk overlooking a pharmaceutical factory floor on the outskirts of the Congolese capital Kinshasa, Joss Ilunga Dijimba, 52, cracked a jovial smile.
"It's not easy doing business in Congo," he said.
His family was forced to relocate the factory in the 1990s to survive bouts of mass looting. And nowadays, there are onerous taxes, customs duties, and problems retaining talented staff.
His company, which employs about 40 people and produces generics such as paracetamol, is one of a tiny number of drug manufacturers in the Democratic Republic of Congo, an impoverished nation roughly the size of Western Europe.
But a government plan to require hospitals and NGOs to buy more locally produced drugs could soon boost the fledgling pharmaceutical industry -- despite fears in some quarters that safety standards are far below international norms.
Several NGOs, some of which provide medical care in the DRC's conflict-torn east, have requested opt-outs.
At the small Pharmagros plant, behind barbed-wire walls near the Congo river, men in hairnets and white coats formulate medicines with imported precursor using lab equipment in airconditioned rooms.
"Promoting local industry's a good thing," said Dijimba, a University of Texas graduate, insisting that several Congolese firms, including his, maintained high standards.
"It could grow the middle class."
About 73 percent of the DRC's population of 90 million lives on under $1.9 a day, according to the World Bank. Most products in the African country are imported.
- 'At your own peril' -
The Congolese government has designated 35 drug molecules, including paracetamol, that medical facilities will be required to purchase in locally made form.
The government wants to stimulate business without banning imports, said Donatien Kabamb Kabey, the pharmaceuticals director at the DRC's health ministry.
He explained that all the molecules can be replaced with imported equivalents, suggesting that ibuprofen could replace paracetamol, for example.
Although not yet implemented, the policy already appears to be working.
Fifteen new pharma businesses are setting up in the DRC ahead of the new rules, Kabey said, which will add to the existing 24.
The policy was partly designed to encourage factories to return after fleeing the country in the 1990s, he added, when unpaid soldiers went on the rampage towards the end of ex-dictator Mobutu Sese Seko's reign.
But experts warn that Congolese-made medicines face a major challenge: reassuring doctors and patients that they meet regulatory standards.
"When you go to the private sector in Congo, you do it at your own peril," said Ed Vreeke, who runs the Belgium-based independent pharmaceutical auditing firm Quamed.
"They know darn well that the quality they produce is not good."
Vreeke said Congolese regulators had improved, but the country lacked the massive resources needed to properly perform audits, check labels, and inspect the chemical composition of drugs for safety.
Kabey, whose department at the health ministry oversees inspections, said standards had improved "enormously" in recent years, but did not provide further details.
He said the government was establishing a national quality-control lab.
- 'A huge thing' -
Shoddy or falsified medicines kill hundreds of thousands of people every year, according to the World Health Organization, mostly in poor countries.
The DRC's hot and humid climate also poses storage problems.
A 2021 study of both imported and locally produced eye drops sold in Kinshasa, for example, showed that three out of the seven products tested were substandard. The one sample manufactured in the DRC was contaminated.
Outside a pharmacy in Kinshasa's upmarket Gombe district, clutching a bag of medicines, 29-year-old corporate lawyer Joelle Mamputu said she didn't pay attention to where drugs were made but said she had "no prejudice".
However, a 52-year-old public servant named Olivier said there was "quite a difference" between Congolese and foreign drugs.
He added he would buy Congolese drugs were the quality the same.
Despite official assurances, major international NGOs such as Doctors Without Borders (MSF) and Medecins du Monde (MDM) have requested opt-outs from the purchasing requirements, several humanitarian workers said.
MSF declined to comment.
MDM confirmed it had asked for an exemption due to concerns over quality and capacity to meet demand.
"It's a huge thing," said one humanitarian who asked for anonymity, explaining that the new rules will affect all non-governmental organisations, hospitals and pharmacies.
Many aid workers understand the need to promote enterprise, he said, but there are internal disagreements about whether to compromise on quality.
"We need to have high quality standards for everyone, but the reality of the country is that sometimes it's impossible".
E.Paulino--PC